AKT1 and pancreatic neoplasm: Moreover, it has been reported that a novel fusicoccin derivative (ISIR-042) was more effective at inducing the growth inhibitory and cytotoxic effects on hypoxic pancreatic cancer cells than on normoxic pancreatic cancer cells in vitro and in vivo through a reduction in HIF-1α and Akt activation [63].